Global COVID-19 Saliva Screening Test Potential Market Set for Strong Expansion Reaching $6.46 Billion by 2030 at 8.4% CAGR
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The COVID-19 Saliva Screening Test Potential Market By 2030 Starting From Its 2026 Size?
The potential market size for the covid-19 saliva screening test has shown robust growth in recent years. This market is forecast to increase from $4.28 billion in 2025 to $4.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. Historically, this growth can be attributed to the discomfort associated with swab-based testing, the need for frequent screening, concerns regarding infection control, the demand for scalable testing solutions, and the response to public health emergencies.
The market for covid-19 saliva screening tests is projected to experience substantial expansion over the coming years. This market is anticipated to reach $6.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. Factors contributing to this growth during the forecast period include upcoming pandemic preparedness initiatives, the rise of decentralized diagnostic approaches, increased workplace testing, the need for affordable mass screening, and advancements in saliva-based technologies. Key trends for this period encompass a move towards non-invasive testing, wider implementation of large-scale community screening, increasing adoption of self-collection tests, their use in busy public areas, and their incorporation into workplace safety protocols.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16026&type=smp
What Primary Drivers Are Shaping The Development Of The COVID-19 Saliva Screening Test Potential Market?
The rising healthcare expenditure is projected to advance the growth of the COVID-19 saliva screening test potential market moving forward. Healthcare expenditure represents the total sum disbursed for goods and services related to healthcare, encompassing prescription medications, hospital stays, physician visits, medical apparatus, and public health campaigns. The increase in healthcare spending is attributable to several factors, such as minimally invasive surgical techniques, state-of-the-art diagnostic tools, heightened research and development for new drugs, greater utilization of healthcare services, and specialized pharmaceuticals. Enhanced healthcare expenditure can provide the necessary funding and support to fully leverage the capabilities of COVID-19 saliva screening tests, contributing to more effective pandemic management and superior public health outcomes. For instance, in December 2024, according to the U.S. Centers for Medicare & Medicaid Services (CMS), a US-based federal health agency, national health-care spending saw a 7.5% increase, reaching US $4.9 trillion, compared to the previous year. Thus, the escalating healthcare expenditure is propelling the expansion of the COVID-19 saliva screening test potential market.
Which Segment Categories Define The COVID-19 Saliva Screening Test Potential Market?
The covid-19 saliva screening test potential market covered in this report is segmented –
1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations
2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
3) By Mode Of Testing: Centralized Testing, Decentralized Testing
Subsegments:
1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports
2) By Sports Arenas: Stadiums, Arenas, Event Halls
3) By Entertainment Venues: Theaters, Concert Halls, Amusement Parks, Nightclubs
4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks
5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas
6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites
7) By Other Locations: Healthcare Facilities, Government Buildings, Public Transportation Hubs, Shopping Centers
What Major Market Trends Are Driving Changes In The COVID-19 Saliva Screening Test Potential Market?
Companies operating in the COVID-19 saliva screening test potential market are concentrating on developing innovative technologies, such as data-sharing platforms. These platforms are intended to improve real-time communication and cooperation among healthcare providers, laboratories, and public health authorities, ultimately enhancing the efficiency and accuracy of testing, tracking, and response efforts throughout the pandemic. Data-sharing platforms function as digital systems that enable the secure exchange of information among various stakeholders, including healthcare providers, researchers, and organizations. They foster collaboration and access to information, which in turn improves decision-making, efficiency, and outcomes across sectors. For example, in May 2024, Mount Sinai Health System, a healthcare network based in the US, inaugurated the Center for Healthcare Readiness. This Center’s primary focus is on refining strategies for public health emergency response, ensuring that healthcare systems are well-equipped to manage large-scale crises like pandemics or natural disasters. It seeks to bolster the capabilities of the Mount Sinai Health System and work with local, regional, and federal partners to formulate extensive preparedness plans.
Who Are The Top Companies Competing In The COVID-19 Saliva Screening Test Potential Market?
Major companies operating in the covid-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene
Read the full covid-19 saliva screening test potential market report here:
How Does The COVID-19 Saliva Screening Test Potential Market Perform Across Major Global Regions?
North America was the largest region in the COVID-19 saliva screening test potential market in 2025. The regions covered in the covid-19 saliva screening test potential market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored COVID-19 Saliva Screening Test Potential Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=16026&type=smp
Browse Through More Reports Similar to the Global COVID-19 Saliva Screening Test Potential Market 2026, By The Business Research Company
Covid 19 Rapid Test Kits Market
https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market
Covid 19 Saliva Screening Test Potential Global Market Report
Infectious Disease Diagnostics Testing Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
